What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Chemotherapy
Nancy E. Kemeny focuses on Colorectal cancer, Internal medicine, Surgery, Chemotherapy and Gastroenterology.
Her Colorectal cancer study deals with the bigger picture of Cancer.
Her Internal medicine study integrates concerns from other disciplines, such as Oncology and Pathology.
Her study in the field of Systemic chemotherapy is also linked to topics like In patient.
Her studies deal with areas such as Artery, Leukocytosis and Toxicity as well as Gastroenterology.
In her research, Physical therapy is intimately related to Randomized controlled trial, which falls under the overarching field of Hepatic arterial infusion.
Her most cited work include:
- The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress (1196 citations)
- ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer (1169 citations)
- Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry (1009 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of investigation include Internal medicine, Colorectal cancer, Chemotherapy, Oncology and Surgery.
Internal medicine is often connected to Gastroenterology in her work.
The various areas that Nancy E. Kemeny examines in her Gastroenterology study include Carcinoembryonic antigen, Carcinoma, Pathology and Toxicity.
Her biological study spans a wide range of topics, including Radiation therapy, Hepatectomy, Metastasis and Survival rate.
Her Chemotherapy study combines topics in areas such as Artery, Rectum, Regimen, Adjuvant and Disease.
Her Oncology research is multidisciplinary, relying on both KRAS, Clinical trial, Incidence and Adjuvant therapy.
She most often published in these fields:
- Internal medicine (64.68%)
- Colorectal cancer (59.34%)
- Chemotherapy (41.48%)
What were the highlights of her more recent work (between 2016-2021)?
- Internal medicine (64.68%)
- Colorectal cancer (59.34%)
- Chemotherapy (41.48%)
In recent papers she was focusing on the following fields of study:
Her primary scientific interests are in Internal medicine, Colorectal cancer, Chemotherapy, Oncology and Gastroenterology.
Her study in the fields of Hepatic arterial infusion, Disease, KRAS and Intrahepatic Cholangiocarcinoma under the domain of Internal medicine overlaps with other disciplines such as In patient.
Colorectal cancer is a subfield of Cancer that Nancy E. Kemeny investigates.
Her research on Chemotherapy concerns the broader Surgery.
Her Oncology research includes themes of BAP1, Incidence, Hepatocellular carcinoma, Hazard ratio and Radiation therapy.
Nancy E. Kemeny has researched Gastroenterology in several fields, including Survival rate, Surgical oncology, Proportional hazards model and Cumulative incidence.
Between 2016 and 2021, her most popular works were:
- Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer (287 citations)
- Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention. (142 citations)
- Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention. (142 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Chemotherapy
Her primary areas of study are Internal medicine, Colorectal cancer, Oncology, Chemotherapy and KRAS.
Her work is dedicated to discovering how Internal medicine, Gastroenterology are connected with Hepatectomy and other disciplines.
Specifically, her work in Colorectal cancer is concerned with the study of Hepatic arterial infusion.
Her Oncology research includes elements of Cancer, Metastasis, Incidence, Univariate analysis and Hazard ratio.
Her Chemotherapy study introduces a deeper knowledge of Surgery.
Nancy E. Kemeny has included themes like Germline mutation and Krukenberg tumor in her Surgery study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
